Acute Porphyria Drug Database

C07AA03 - Pindolol
Propably not porphyrinogenic
PNP

Rationale
Beta-blocker. Clinical experience and wo references point to non-porphyrinogenicity.
Chemical description
Beta-receptor blocking agent used in hypertonia, angina pectoris, tachyarrythmia. Eliminated unchanged (30 -40%) and as metabolites. Thunell, patient reports (n=3): tolerated. Andersson, patient report (n=3): tolerated. South African list: use. EPI: safe (betablockers)
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes C07A / C07AA or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙